Healthcare Triangle, Inc.
HCTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -0.00 | -162.80 | -2,857.70 |
| FCF Yield | -7.65% | -20.14% | -0.02% | -0.00% |
| EV / EBITDA | -3.79 | -9.85 | -23,675.73 | -156,311.06 |
| Quality | ||||
| ROIC | -14.50% | -11.49% | -14.95% | 20.27% |
| Gross Margin | 17.71% | 13.88% | 8.88% | 11.69% |
| Cash Conversion Ratio | 1.03 | 1.93 | 3.27 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -29.82% | -34.18% | -36.77% | -36.60% |
| Free Cash Flow Growth | 72.39% | 41.73% | -585.20% | -213.43% |
| Safety | ||||
| Net Debt / EBITDA | 0.61 | 2.09 | 4.75 | -4.14 |
| Interest Coverage | 80.97 | -64.71 | -3.38 | -0.58 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 21.96 | 70.16 | 3.19 | -72.54 |